Pokey, you are right. Original PR on 2/27/2020. Sa
Post# of 36537
“The terms of the contract, which have been agreed to in writing by both parties, include an upfront payment of $1 million to initiate the project work in the United States, a $5 million licensing fee for the Ii-Key technology, payment by the Chinese consortium for all costs and expenses related to the development of a COVID-19 vaccine, and a 20% royalty on each dose of vaccine produced.”
https://finance.yahoo.com/news/generex-provid...31898.html